Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
37.64
-2.69 (-6.67%)
Mar 31, 2025, 10:54 AM EDT - Market open
Monopar Therapeutics Employees
As of December 31, 2023, Monopar Therapeutics had 10 total employees, including 9 full-time and 1 part-time employees. The number of employees decreased by 2 or -16.67% compared to the previous year.
Employees
10
Change (1Y)
-2
Growth (1Y)
-16.67%
Revenue / Employee
n/a
Profits / Employee
-$647,473
Market Cap
229.55M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MNPR News
- 2 hours ago - Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments - GlobeNewsWire
- 2 months ago - Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics - PRNewsWire
- 3 months ago - Monopar: Radiopharmaceutical Company With 2 Radioisotope Development Pathways - Seeking Alpha
- 3 months ago - Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants - GlobeNewsWire
- 4 months ago - Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu - GlobeNewsWire
- 4 months ago - Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference - GlobeNewsWire
- 4 months ago - Monopar Therapeutics: Radiopharmaceuticals And Rare Disease Potential In Focus - Seeking Alpha
- 5 months ago - Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments - GlobeNewsWire